Provided by Tiger Fintech (Singapore) Pte. Ltd.

Healthcare Realty Trust Inc

16.00
+0.30001.91%
Post-market: 16.000.00000.00%16:31 EDT
Volume:3.13M
Turnover:50.04M
Market Cap:5.61B
PE:-8.84
High:16.11
Open:15.70
Low:15.70
Close:15.70
Loading ...

Zuora (NYSE:ZUO) Q2 Earnings: Leading The Finance and HR Software Pack

StockStory
·
31 Jan

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

Business Wire
·
31 Jan

Exa Enterprise AI Launches Secure Generative AI for HR Operations

TIPRANKS
·
30 Jan

Japan's ExaWizards Unveils HR Data-Driven Talent Visualization Service

MT Newswires Live
·
29 Jan

Xiao-I Corporation Delivers Transformative AI-Powered HR Solution to Hong Kong Public Sector, Showcasing Scalable MaaS Excellence

PR Newswire
·
28 Jan

IMNN: Gearing Up to Initiate Phase 3 Ovarian Cancer Trial in 1Q25…

Zacks Small Cap Research
·
28 Jan

ExaWizards Launches AI-Powered HR Assessment Service

TIPRANKS
·
28 Jan

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

Business Wire
·
28 Jan

Bacui Technologies Expands HR Outsourcing in China through New Joint Venture

TIPRANKS
·
26 Jan

Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call

GlobeNewswire
·
24 Jan

Hackett Finds Rapid Advancement in AI and Automation Transforms Talent Acquisition Technology

Business Wire
·
23 Jan

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

Benzinga
·
22 Jan

Iron Mountain Incorporated (IRM): Strong Financial Growth and Innovative AI-Driven Solutions Transforming Storage and HR Operations

Insider Monkey
·
19 Jan

Why Are Analysts Bullish On Alight, Inc. (ALIT) Now?

Insider Monkey
·
19 Jan

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer

Business Wire
·
18 Jan

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

PR Newswire
·
17 Jan

78% of Fortune 500 HR leaders say they have trouble getting the C-suite to believe in the long-term benefits of childcare

Fortune
·
16 Jan

Live Verdure’s AI subsidiary Decidr lands partnerships in UGC and proptech sectors

Stockheads
·
16 Jan

Fortune 500 HR Leaders Say Flexible, Employer-Sponsored Child Care Benefits Are Essential for Employers in Today’s Market

Business Wire
·
15 Jan

Renaissance Global Announces HR Head Resignation

TIPRANKS
·
15 Jan